Gupta Suneel
SEC CIK 1763923 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Chief Development Off | 256.2K | — | $5.76M | 13 | 2022-02-15 | 2024-11-25 |
Most active insiders at PTGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PATEL DINESH V PH D | Pres, CEO, Dir | — | $60.58M |
| 2 | Ali Asif | CFO | — | $7.32M |
| 3 | Giraudo Bryan | Dir | — | $5.92M |
| 4 | Waddill William D. | Dir | — | $5.58M |
| 5 | MOLINA ARTURO MD | Chief Medical Off | — | $4.49M |
| 6 | SELICK HAROLD E | Dir | — | $2.52M |
| 7 | Williams Lewis T | Dir | — | $1.48M |
| 8 | O'Dowd Sarah A | Dir | — | — |
Gupta Suneel made no open-market trades at PTGX in the last 12 months.
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-27 | 2024-11-25+ | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | S - Sale+OE | $45.96 | -122.6K | 256.2K | -32% | -$5.64M |
| DM | 2024-11-27 | 2024-11-25+ | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | M - OptEx | $8.40 | +205.4K | 267.4K | +331% | +$1.73M |
| 2024-02-28 | 2024-02-26 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | F - Tax | $29.53 | -4,282 | 183.3K | -2% | -$126.4K | |
| D | 2024-01-11 | 2024-01-09 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +5,000 | 192.6K | +3% | +$36.9K |
| D | 2024-01-11 | 2024-01-09 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | S - Sale+OE | $25.00 | -5,000 | 187.6K | -3% | -$125.0K |
| D | 2024-01-04 | 2024-01-02 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +19.2K | 187.6K | +11% | $0 |
| D | 2023-10-23 | 2023-10-19 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +20.0K | 168.3K | +13% | +$147.6K |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | F - Tax | $26.07 | -4,150 | 148.0K | -3% | -$108.2K | |
| 2023-06-02 | 2023-05-31 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +12.0K | 152.2K | +9% | $0 | |
| D | 2023-01-18 | 2023-01-16 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +20.6K | 138.2K | +18% | $0 |
| D | 2022-04-26 | 2022-04-26 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | M - OptEx | $7.38 | +40.0K | 117.6K | +52% | +$295.2K |
| 2022-03-02 | 2022-02-28 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | F - Tax | $24.28 | -649 | 77.0K | -0.8% | -$15.8K | |
| D | 2022-02-17 | 2022-02-15 | PTGX | Protagonist Therapeutics, Inc | Gupta Suneel | Chief Development Off | A - Grant | $0.00 | +12.5K | 77.7K | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations